Indeed, higher expression of CD11a (LFA-1 α-chain) on CLL cells has been associated with increase in tumor burden (225) and higher expression of CD49d (VLA-4 α-chain) with disease progression and decreased overall survival (229–231). Here, ITGB2 is linked to B-cell chronic lymphocytic leukemia.